Home  >  Health Check  >  Milestone in HIV prevention for women
Health Check
Milestone in HIV prevention for women
Health Check
Dec 2, 2020

In the week of World AIDS Day, Health Check looks at what's being described as a milestone in the prevention of HIV infection in women. It is a form of pre-exposure prophylaxis (PrEP) - an injection every 8 weeks of a drug called cabotegravir. A clinical trial has been comparing it to a daily PrEP pill which is already known to be effective at preventing HIV infection. The injection regimen was about 90% more effective at shielding women from the virus than the daily tablet. The trial involves more than 3,000 women in seven Southern and East African countries. Claudia talks to study co-leader Sinead Delany-Moretlwe of the University of Witwatersrand about why this form of PrEP seems to be so effective and whether it will be affordable for low and middle income countries. Chhavi Sachdev reports on informal health workers known as ‘chhota doctors’ who are the backbone of primary health care for the hundreds of millions of rural people in India. They are not formally recognised as health care providers by the authorities and lack medical degrees, but they are the first port of call for many when people feel ill, particularly during India’s coronavirus lockdown. At a time when so many people are stuck indoors working at home, World Health Organisation has published new recommendations on how much physical activity we should be doing for the sake of our health. We talk to Fiona Bull, head of the WHO’s physical activity unit. James Gallagher is the Health Check guest this week talking about Covid-19 vaccines, vitamin D and a step towards a blood test to predict Alzheimer’s disease.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: Female doctor giving a young female patient an injection in her consultation room. Photo credit: Henk Badenhorst/Getty Images.)

More Episodes


Mar 25, 2026
Antimicrobial resistance in conflict zones

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Mar 18, 2026
Does your home country impact your cancer risk?

North Korean defectors and lifelong South Korean residents have significantly different cancer rates, despite their genetic similarities; new research finds. Presenter Laura Foster unpacks this study, explaining what it tells us about how upbringing and environment contribute to different cancer rates, and how migration can change these risks.

A new study has found GLP-1s – drugs typically used to treat diabetes and obesity – could have an unexpected benefit for patients dealing with substance abuse disorders. Laura speaks with Ziyad Al-Aly, a clinical epidemiologist and Veterans Affairs physician at Washington University in St Louis to understand what this could mean for treating drug and alcohol addictions, and what questions still need answers before this treatment can be rolled out.

Last weekend, Kenya’s National Environment Management Authority rolled out new waste management rules to better dispose of products containing plastic, but the new laws are expected to increase the price of sanitary pads by 20%. Global health reporter based in Nairobi, Dorcas Wangira joins Laura to unpack what these policies mean for the accessibility of sanitary products, and what alternative solutions are needed to balance access with environmental impact. They also discuss how a drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method.

And Jane Chambers reports from Peru about the growing prevalence of anaemia, speaking to local healthcare workers about what steps families can be taken to help their children recover.

Presenter: Laura Foster Producers: Jonathan Blackwell and Georgia Christie


26min 28sec

Milestone in HIV prevention for women

--:--
--:--